V030-2831 Screening compound: 3-[3-(4-chlorophenoxy)phenyl]-N-[2-(morpholin-4-yl)ethyl]-3-(5-nitro-1H-indol-3-yl)propanamide

V030-2831 Screening compound: 3-[3-(4-chlorophenoxy)phenyl]-N-[2-(morpholin-4-yl)ethyl]-3-(5-nitro-1H-indol-3-yl)propanamide
V030-2831 Screening compound: 3-[3-(4-chlorophenoxy)phenyl]-N-[2-(morpholin-4-yl)ethyl]-3-(5-nitro-1H-indol-3-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-2831
3-[3-(4-chlorophenoxy)phenyl]-N-[2-(morpholin-4-yl)ethyl]-3-(5-nitro-1H-indol-3-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-2831

Molecular Formula

C29H29ClN4O5 (C29 H29 ClN4 O5)

Compound Name

3-[3-(4-chlorophenoxy)phenyl]-N-[2-(morpholin-4-yl)ethyl]-3-(5-nitro-1H-indol-3-yl)propanamide

IUPAC name

3-[3-(4-chlorophenoxy)phenyl]-N-[2-(morpholin-4-yl)ethyl]-3-(5-nitro-1H-indol-3-yl)propanamide

SMILES

[O-][N+](c(cc1)cc2c1[nH]cc2C(CC(NCCN1CCOCC1)=O)c1cccc(Oc(cc2)ccc2Cl)c1)=O

InChI

InChI=1S/C29H29ClN4O5/c30-21-4-7-23(8-5-21)39-24-3-1-2-20(16-24)25(18-29(35)31-10-11-33-12-14-38-15-13-33)27-19-32-28-9-6-22(34(36)37)17-26(27)28/h1-9,16-17,19,25,32H,10-15,18H2,(H,31,35)/t25-/m1/s1

InChI Key

YEMNDZAREITVCO-RUZDIDTESA-N

MDL Number (MFCD)

MFCD19779437

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

549.03

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.843

Distribution Coefficient, logD

4.767

Water Solubility, LogSw

-5.18

Polar Surface Area

85.899

Acid Dissociation Constant (pKa)

12.78

Base Dissociation Constant (pKb)

6.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

27.60

V030-2831 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Indole Derivatives (10091 compounds)

MCL1 Targeted Library (12200 compounds)

PI3K-Targeted Library (17255 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Structure:
  • Cyclic compounds
Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V030-2831 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-2831?
Check Price and Availability of V030-2831, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-2831 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-2831
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-2831
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-2831 available by request